Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ranbaxy Labora Ranbaxy Laboratories Ltd. | BSE 859.90 0.00 (0.00%) | NSE 859.80 0.00 (0.00%) | Trade | Add

BSE Live

Apr 01, 16:00

859.90 0.00 (0.00%)

Volume

No Data Available

308,222

Prev. Close

859.90
Open Price

814.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59

859.80 0.00 (0.00%)

Volume

No Data Available

5,415,702

Prev. Close

859.80
Open Price

814.70

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
859.80 (9924)

Ranbaxy Laboratories is not traded on NSE in the last 30 days

Financials

Download Annual Report in PDF format 2021 2020 2019 2018 2017

Print/Copy to Excel : Go

Quarterly Results of Ranbaxy Laboratories (in Rs. Cr.)	Dec '14	Sep '14	Jun '14	Mar '14	Dec '13
Net Sales/Income from operations	956.52	1,272.69	2,116.98	1,224.59	1,327.64
Other Operating Income	53.33	46.23	61.65	27.43	38.93
Total Income From Operations	1,009.85	1,318.91	2,178.63	1,252.02	1,366.56
EXPENDITURE
Consumption of Raw Materials	314.13	335.94	280.73	394.87	432.75
Purchase of Traded Goods	228.86	227.01	184.27	224.77	219.36
Increase/Decrease in Stocks	46.07	101.17	102.74	3.29	-82.70
Power & Fuel	--	--	--	--	--
Employees Cost	271.89	279.67	254.74	226.27	271.91
depreciat	54.81	60.15	65.65	49.98	45.85
Excise Duty	--	--	--	--	--
Admin. And Selling Expenses	--	--	--	--	--
R & D Expenses	--	--	--	--	--
Provisions And Contingencies	--	--	--	--	--
Exp. Capitalised	--	--	--	--	--
Other Expenses	500.41	530.80	429.76	440.48	591.29
P/L Before Other Inc. , Int., Excpt. Items & Tax	-406.32	-215.82	860.74	-87.64	-111.90
Other Income	17.75	20.02	25.76	636.50	20.60
P/L Before Int., Excpt. Items & Tax	-388.56	-195.80	886.50	548.86	-91.30
Interest	149.31	136.82	141.91	110.85	118.39
P/L Before Exceptional Items & Tax	-537.87	-332.63	744.59	438.02	-209.69
Exceptional Items	-27.27	-35.63	19.77	490.41	-186.28
P/L Before Tax	-565.14	-368.26	764.36	928.43	-395.96
Tax	855.35	--	9.24	30.57	--
P/L After Tax from Ordinary Activities	-1,420.49	-368.26	755.12	897.86	-395.96
Prior Year Adjustments	--	--	--	--	--
Extra Ordinary Items	--	--	--	--	--
Net Profit/(Loss) For the Period	-1,420.49	-368.26	755.12	897.86	-395.96
Equity Share Capital	212.24	211.95	211.78	211.66	211.55
Reserves Excluding Revaluation Reserves	--	--	--	--	--
Equity Dividend Rate (%)	--	--	--	--	--
EPS Before Extra Ordinary
Basic EPS	-33.47	-8.69	17.83	21.22	-9.36
Diluted EPS	-33.47	-8.69	17.80	21.19	-9.36
EPS After Extra Ordinary
Basic EPS.	-33.47	-8.69	17.83	21.22	-9.36
Diluted EPS.	-33.47	-8.69	17.80	21.19	-9.36
Public Share Holding
No Of Shares (Crores)	15.63	14.93	14.49	14.88	14.80
Share Holding (%)	36.77	35.22	34.18	35.11	34.93
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--	--	--
b) Non-encumbered
- Number of shares (Crores).	26.87	26.87	26.87	26.87	26.87
- Per. of shares (as a % of the total sh. of prom. and promoter group).	100.00	100.00	100.00	100.00	100.00
- Per. of shares (as a % of the total Share Cap. of the company).	63.22	63.37	63.40	63.41	63.41